Core Insights - The article highlights the growing consumer demand for high-quality and healthy edible oils, with Kexian Group launching a first-grade rapeseed oil product to meet this trend [2][11] Group 1: Company Overview - Kexian Group has been deeply involved in the health industry for 21 years, evolving from a medical device company to a diversified health industry group covering various sectors [3] - The company has established a strong technical foundation and market reputation, accumulating multiple patents to create a solid technological barrier [3] - Kexian's core product, the electric thermal therapy device, has received certification as a Class II medical device, enhancing its competitive edge [3] Group 2: Product Launch - The introduction of first-grade rapeseed oil enriches Kexian's health product matrix and signifies its expansion into the health food sector [2][6] - The rapeseed oil is designed to meet consumer needs for healthy oils, showcasing strict quality control in raw material selection and processing [7][11] - Kexian's rapeseed oil contains over 60% unsaturated fatty acids and is rich in vitamin E and phytosterols, promoting cardiovascular health [7] Group 3: Quality Control - Kexian has established a rigorous quality control system covering the entire supply chain, ensuring compliance with national standards [8][10] - The company collaborates with high-quality rapeseed planting bases to monitor the cultivation process, ensuring no pesticide residues or heavy metal exceedances [10] - Advanced production facilities and a professional testing team are in place to guarantee product safety and quality [10] Group 4: Strategic Alignment - The launch of the rapeseed oil aligns with the "Healthy China 2030" strategy, reflecting Kexian's commitment to enhancing public health awareness [11][12] - Kexian's expansion into health foods complements its existing health ecosystem, providing comprehensive health solutions for consumers [12] - The initiative demonstrates Kexian's ability to leverage cross-industry integration and full supply chain layout to tap into the health industry's growth potential [12]

Core Viewpoint - The opening of the second phase of the Haier Kangyang Ganzhou Science and Technology Park marks a significant achievement in the collaboration between local government and leading enterprises to promote high-quality development in the health industry, establishing a benchmark for urban renewal projects in Ganzhou [1][2]. Group 1: Project Overview - The Haier Kangyang Ganzhou Science and Technology Park is a key project aimed at transforming the local economy by integrating industry and urban development, with a focus on the health sector [1][2]. - The second phase of the park covers approximately 23,000 square meters and includes advanced medical equipment testing laboratories, smart manufacturing applications, and aims for an annual production capacity of 6 million units [7]. Group 2: Business Growth and Performance - Since its establishment in Ganzhou in 2021, Haier Kangyang has achieved rapid growth, with sales exceeding 700 million yuan and the completion of the second phase expansion [2][3]. - The first phase of production generated revenue of 80 million yuan in its initial year, expanding its product line to over 20 categories, including oxygen generation and health monitoring devices [3]. Group 3: Technological Innovation - Haier Kangyang focuses on smart manufacturing and has been recognized as a high-tech enterprise in Jiangxi Province, showcasing its commitment to technological advancement and industry integration [3]. - The company has developed a comprehensive product matrix covering over 100 types of home health products, particularly excelling in the field of respiratory health with its innovative oxygen machines [8][9]. Group 4: Strategic Vision - The company aims to address the challenges of an aging population through technological innovation, with plans to leverage the Kaos industrial internet platform for product manufacturing and ecosystem development [9]. - Haier Kangyang is committed to deepening government-enterprise collaboration and optimizing the health industry ecosystem, contributing to the implementation of the Healthy China strategy [9].